Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Technology Insight: magnetic resonance angiography for the evaluation of patients with peripheral artery disease

Abstract

Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis. Although clinical history in conjunction with ankle–brachial index and evaluation of segmental pressures/waveforms is sufficient to diagnose PAD in a large percentage of patients, imaging is required for disease localization and treatment planning. Contrast-enhanced magnetic resonance angiography (CE-MRA) is a noninvasive, three-dimensional technique that has emerged as a front-line imaging approach for comprehensive evaluation of PAD. Technical advances such as parallel imaging and moving-table, time-resolved angiography and extended field-of-view approaches have greatly improved the accuracy of CE-MRA. In the clinical setting, CE-MRA can be extremely helpful in the initial diagnosis as well as subsequent management of patients with PAD. Continued hardware and software improvements will enable further refinements in imaging protocol for peripheral MRA, consolidating its clinical role for the evaluation of patients with PAD.

Key Points

  • Peripheral arterial disease (PAD) represents a common manifestation of systemic atherosclerosis

  • Peripheral magnetic resonance angiography (MRA) could aid in the management of patients with PAD and, in particular, in those with an indication for revascularization

  • MRA techniques, with and without contrast, can be used in the study of lower-extremity vessels; however, contrast-enhanced MRA represent the preferred approach because of its ability to provide a high-resolution three-dimensional data-set of images

  • High-quality peripheral MRA studies incorporate a series of technical advancements (e.g. moving-table technique, parallel imaging, strategies for correct timing of image acquisition)

  • With peripheral contrast-enhanced MRA, unwanted venous contrast opacification during image acquisition at the calf level (venous contamination) remains one of the most common pitfalls

  • Peripheral MRA is a safe and accurate technique for the diagnosis and management of lower-extremity arterial disease, with important advantages such as safety, higher diagnostic accuracy and better repeatability when compared with other techniques such as invasive angiography CT angiography and duplex ultrasonography

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Black-blood imaging of the superficial femoral artery (magnified in the insert) revealing the absence of atherosclerotic disease.
Figure 2: Contrast-enhanced magnetic resonance angiography of the peripheral vasculature.
Figure 3: Peripheral contrast-enhanced magnetic resonance angiography with moving-table technique.
Figure 4: Dedicated time-resolved contrast-enhanced magnetic resonance angiography of the legs showing progressive contrast opacification of distal circulation during (A) initial, (B) intermediate and (C) late time frames.
Figure 5: Suggested diagnostic algorithm in patients with known or suspected peripheral artery disease.
Figure 6: Ilio-femoral arterial disease detected by contrast-enhanced magnetic resonance angiography.
Figure 7: Multistation contrast-enhanced magnetic resonance angiographies for peripheral vessel disease.

Similar content being viewed by others

References

  1. Ouriel K (2001) Peripheral arterial disease. Lancet 358: 1257–1264

    Article  CAS  Google Scholar 

  2. Hirsch AT et al. (2006) ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113: e463–e654

    Article  Google Scholar 

  3. Criqui MH et al. (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381–386

    Article  CAS  Google Scholar 

  4. Papamichael CM et al. (2000) Ankle–brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 86: 615–618

    Article  CAS  Google Scholar 

  5. McDermott MM et al. (2004) Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 292: 453–461

    Article  CAS  Google Scholar 

  6. Gale SS et al. (1998) Lower extremity arterial evaluation: are segmental arterial blood pressures worthwhile. J Vasc Surg 27: 831–838

    Article  CAS  Google Scholar 

  7. Prince MR et al. (1993) Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 3: 877–881

    Article  CAS  Google Scholar 

  8. Rubin GD et al. (2001) Multi-detector row CT angiography of lower extremity arterial inflow and runoff: initial experience. Radiology 221: 146–158

    Article  CAS  Google Scholar 

  9. Yuan C et al. (2001) Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 221: 285–299

    Article  CAS  Google Scholar 

  10. Fayad ZA et al. (2000) Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102: 506–510

    Article  CAS  Google Scholar 

  11. Fayad ZA et al. (2000) In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation 101: 2503–2509

    Article  CAS  Google Scholar 

  12. Trivedi RA et al. (2004) MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 46: 738–743

    Article  Google Scholar 

  13. Yuan C et al. (2001) In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104: 2051–2056

    Article  CAS  Google Scholar 

  14. Coulden RA et al. (2000) High resolution magnetic resonance imaging of atherosclerosis and the response to balloon angioplasty. Heart 83: 188–191

    Article  CAS  Google Scholar 

  15. Heverhagen JT et al. (2000) Quantitative human in vivo evaluation of high resolution MRI for vessel wall morphometry after percutaneous transluminal angioplasty. Magn Reson Imaging 18: 985–989

    Article  CAS  Google Scholar 

  16. Meissner OA et al. (2003) High-resolution MR imaging of human atherosclerotic femoral arteries in vivo: validation with intravascular ultrasound. J Vasc Interv Radiol 14: 227–231

    Article  Google Scholar 

  17. Wyttenbach R et al. (2004) Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 110: 1156–1161

    Article  Google Scholar 

  18. McCauley TR et al. (1994) Peripheral vascular occlusive disease: accuracy and reliability of time-of-flight MR angiography. Radiology 192: 351–357

    Article  CAS  Google Scholar 

  19. Goyen M et al. (2005) MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 236: 825–833

    Article  Google Scholar 

  20. Tongdee R et al. (2006) Hybrid peripheral 3D contrast-enhanced MR angiography of calf and foot vasculature. AJR Am J Roentgenol 186: 1746–1753

    Article  Google Scholar 

  21. Leiner T et al. (2004) Comparison of contrast-enhanced magnetic resonance angiography and digital subtraction angiography in patients with chronic critical ischemia and tissue loss. Invest Radiol 39: 435–444

    Article  Google Scholar 

  22. Korosec FR et al. (1996) Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 36: 345–351

    Article  CAS  Google Scholar 

  23. Du J et al. (2002) Time-resolved, undersampled projection reconstruction imaging for high-resolution CE-MRA of the distal runoff vessels. Magn Reson Med 48: 516–522

    Article  CAS  Google Scholar 

  24. Madhuranthakam AJ . et al. (2004) Time-resolved 3D contrast-enhanced MRA of an extended FOV using continuous table motion. Magn Reson Med 51: 568–576

    Article  Google Scholar 

  25. Zhang HL et al. (2004) Decreased venous contamination on 3D gadolinium-enhanced bolus chase peripheral MR angiography using thigh compression. AJR Am J Roentgenol 183: 1041–1047

    Article  Google Scholar 

  26. Vogt FM et al. (2004) Venous compression at high-spatial-resolution three-dimensional MR angiography of peripheral arteries. Radiology 233: 913–920

    Article  Google Scholar 

  27. Goyen M et al. (2002) Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole-body 3D magnetic resonance angiography. Invest Radiol 37: 263–268

    Article  Google Scholar 

  28. Khan NA et al. (2006) Does the clinical examination predict lower extremity peripheral arterial disease. JAMA 295: 536–546

    Article  CAS  Google Scholar 

  29. Dormandy JA and Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31 (Suppl): S1–S296

    CAS  PubMed  Google Scholar 

  30. Bertschinger K et al. (2001) Surveillance of peripheral arterial bypass grafts with three-dimensional MR angiography: comparison with digital subtraction angiography. AJR Am J Roentgenol 176: 215–220

    Article  CAS  Google Scholar 

  31. Hofmann WJ et al. (2002) Pedal artery imaging—a comparison of selective digital subtraction angiography, contrast enhanced magnetic resonance angiography and duplex ultrasound. Eur J Vasc Endovasc Surg 24: 287–292

    Article  CAS  Google Scholar 

  32. Dorweiler B et al. (2002) Magnetic resonance angiography unmasks reliable target vessels for pedal bypass grafting in patients with diabetes mellitus. J Vasc Surg 35: 766–772

    Article  Google Scholar 

  33. Lapeyre M et al. (2005) Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 185: 1641–1650

    Article  Google Scholar 

  34. Eiberg JP et al. (2001) Peripheral vascular surgery and magnetic resonance arteriography—a review. Eur J Vasc Endovasc Surg 22: 396–402

    Article  CAS  Google Scholar 

  35. Steffens JC et al. (2003) Bolus-chasing contrast-enhanced 3D MRA of the lower extremity: comparison with intraarterial DSA. Acta Radiol 44: 185–192

    Article  CAS  Google Scholar 

  36. Goyen M and Debatin JF (2004) Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: dosing, safety, and efficacy. J Magn Reson Imaging 19: 261–273

    Article  Google Scholar 

  37. Storto ML and Battista D (2003) Advances in vascular and cardiac MDCT imaging: peripheral arteries. Eur Radiol 13 (Suppl 3): N59–N62

    Article  Google Scholar 

  38. Jakobs TF et al. (2004) MDCT-imaging of peripheral arterial disease. Semin Ultrasound CT MR 25: 145–155

    Article  Google Scholar 

  39. Ota H et al. (2004) MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images. AJR Am J Roentgenol 182: 201–209

    Article  Google Scholar 

  40. O'Hare AM et al. (2005) Low ankle–brachial index associated with rise in creatinine level over time: results from the atherosclerosis risk in communities study. Arch Intern Med 165: 1481–1485

    Article  Google Scholar 

  41. Ouwendijk R et al. (2005) Interobserver agreement for the interpretation of contrast-enhanced 3D MR angiography and MDCT angiography in peripheral arterial disease. AJR Am J Roentgenol 185: 1261–1267

    Article  Google Scholar 

  42. Roth SM and Bandyk DF (1999) Duplex imaging of lower extremity bypasses, angioplasties, and stents. Semin Vasc Surg 12: 275–284

    CAS  PubMed  Google Scholar 

  43. Leiner T et al. (2005) Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology 235: 699–708

    Article  Google Scholar 

  44. Gjonnaess E et al. (2006) Gadolinium-enhanced magnetic resonance angiography, colour duplex and digital subtraction angiography of the lower limb arteries from the aorta to the tibio-peroneal trunk in patients with intermittent claudication. Eur J Vasc Endovasc Surg 31: 53–58

    Article  CAS  Google Scholar 

  45. Goyen M et al. (2002) Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 224: 270–277

    Article  Google Scholar 

  46. Goyen M et al. (2003) Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography—initial experience. Radiology 227: 277–282

    Article  Google Scholar 

  47. Ruehm SG et al. (2001) Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357: 1086–1091

    Article  CAS  Google Scholar 

  48. Fenchel M et al. (2005) Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn Reson Imaging 21: 596–603

    Article  Google Scholar 

  49. Pennell DJ et al. (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25: 1940–1965

    Article  Google Scholar 

  50. Rofsky NM et al. (1997) Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 205: 163–169

    Article  CAS  Google Scholar 

  51. Yamashita Y et al. (1998) Three-dimensional high-resolution dynamic contrast-enhanced MR angiography of the pelvis and lower extremities with use of a phased array coil and subtraction: diagnostic accuracy. J Magn Reson Imaging 8: 1066–1072

    Article  CAS  Google Scholar 

  52. Ho KY et al. (1998) Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology 206: 683–692

    Article  CAS  Google Scholar 

  53. Sueyoshi E et al. (1999) Aortoiliac and lower extremity arteries: comparison of three-dimensional dynamic contrast-enhanced subtraction MR angiography and conventional angiography. Radiology 210: 683–688

    Article  CAS  Google Scholar 

  54. Meaney JF et al. (1999) Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211: 59–67

    Article  CAS  Google Scholar 

  55. Winterer JT et al. (1999) Contrast-enhanced subtraction MR angiography in occlusive disease of the pelvic and lower limb arteries: results of a prospective intraindividual comparative study with digital subtraction angiography in 76 patients. J Comput Assist Tomogr 23: 583–589

    Article  CAS  Google Scholar 

  56. Ruehm SG et al. (2000) Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 174: 1127–1135

    Article  CAS  Google Scholar 

  57. Huber A et al. (2000) Dynamic contrast-enhanced MR angiography from the distal aorta to the ankle joint with a step-by-step technique. AJR Am J Roentgenol 175: 1291–1298

    Article  CAS  Google Scholar 

  58. Loewe C et al. (2002) Peripheral vascular occlusive disease: evaluation with contrast-enhanced moving-bed MR angiography versus digital subtraction angiography in 106 patients. AJR Am J Roentgenol 179: 1013–1021

    Article  Google Scholar 

  59. Hentsch A et al. (2003) Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography. Eur Radiol 13: 2103–2114

    Article  Google Scholar 

  60. Herborn CU et al. (2004) Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol 182: 1427–1434

    Article  Google Scholar 

  61. Krause U et al. (2005) Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection. J Magn Reson Imaging 21: 449–454

    Article  Google Scholar 

  62. Janka R et al. (2005) Contrast-enhanced MR angiography of peripheral arteries including pedal vessels at 1.0 T: feasibility study with dedicated peripheral angiography coil. Radiology 235: 319–326

    Article  Google Scholar 

  63. Fenchel M et al. (2006) Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results. Radiology 238: 280–291

    Article  Google Scholar 

  64. Quick HH et al. (2004) High spatial resolution whole-body MR angiography featuring parallel imaging: initial experience [German]. Rofo 176: 163–169

    Article  CAS  Google Scholar 

  65. Herborn CU et al. (2004) Peripheral vasculature: whole-body MR angiography with midfemoral venous compression—initial experience. Radiology 230: 872–878

    Article  Google Scholar 

  66. Ruehm SG et al. (2004) Whole body MR angiography screening. Int J Cardiovasc Imaging 20: 587–591

    Article  Google Scholar 

  67. Brennan DD et al. (2005) Contrast-enhanced bolus-chased whole-body MR angiography using a moving tabletop and quadrature body coil acquisition. AJR Am J Roentgenol 185: 750–755

    Article  Google Scholar 

  68. Kramer H et al. (2005) Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology 236: 300–310

    Article  Google Scholar 

  69. Hansen T et al. (2006) Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol 16: 147–153

    Article  Google Scholar 

Download references

Acknowledgements

Charles P Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanjay Rajagopalan.

Ethics declarations

Competing interests

OP Simonetti has served as Director of Cardiovascular MRI Research and Development at Siemens Medical Solutions, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dellegrottaglie, S., Sanz, J., Macaluso, F. et al. Technology Insight: magnetic resonance angiography for the evaluation of patients with peripheral artery disease. Nat Rev Cardiol 4, 677–687 (2007). https://doi.org/10.1038/ncpcardio1035

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1035

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing